Suppr超能文献

HCF-1 通过与 ChREBP 形成的营养感应复合物调节从头合成脂肪。

HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP.

机构信息

The Biological and Biomedical Sciences Program, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Mol Cell. 2019 Jul 25;75(2):357-371.e7. doi: 10.1016/j.molcel.2019.05.019. Epub 2019 Jun 18.

Abstract

Carbohydrate response element binding protein (ChREBP) is a key transcriptional regulator of de novo lipogenesis (DNL) in response to carbohydrates and in hepatic steatosis. Mechanisms underlying nutrient modulation of ChREBP are under active investigation. Here we identify host cell factor 1 (HCF-1) as a previously unknown ChREBP-interacting protein that is enriched in liver biopsies of nonalcoholic steatohepatitis (NASH) patients. Biochemical and genetic studies show that HCF-1 is O-GlcNAcylated in response to glucose as a prerequisite for its binding to ChREBP and subsequent recruitment of OGT, ChREBP O-GlcNAcylation, and activation. The HCF-1:ChREBP complex resides at lipogenic gene promoters, where HCF-1 regulates H3K4 trimethylation to prime recruitment of the Jumonji C domain-containing histone demethylase PHF2 for epigenetic activation of these promoters. Overall, these findings define HCF-1's interaction with ChREBP as a previously unappreciated mechanism whereby glucose signals are both relayed to ChREBP and transmitted for epigenetic regulation of lipogenic genes.

摘要

碳水化合物反应元件结合蛋白(ChREBP)是碳水化合物反应和肝脂肪变性中从头合成脂肪(DNL)的关键转录调节因子。目前正在积极研究营养素调节 ChREBP 的机制。在这里,我们确定宿主细胞因子 1(HCF-1)作为一种先前未知的 ChREBP 相互作用蛋白,在非酒精性脂肪性肝炎(NASH)患者的肝活检中富集。生化和遗传研究表明,HCF-1 在葡萄糖的作用下发生 O-GlcNAc 化,这是其与 ChREBP 结合以及随后招募 OGT、ChREBP O-GlcNAc 化和激活的前提。HCF-1:ChREBP 复合物位于脂肪生成基因启动子上,其中 HCF-1 调节 H3K4 三甲基化,为 Jumonji C 结构域包含的组蛋白去甲基酶 PHF2 的募集奠定基础,从而对这些启动子进行表观遗传激活。总的来说,这些发现定义了 HCF-1 与 ChREBP 的相互作用是一种以前未被重视的机制,通过这种机制,葡萄糖信号既可以传递给 ChREBP,也可以传递给表观遗传调节脂肪生成基因。

相似文献

1
HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP.
Mol Cell. 2019 Jul 25;75(2):357-371.e7. doi: 10.1016/j.molcel.2019.05.019. Epub 2019 Jun 18.
2
Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Diabetologia. 2023 May;66(5):931-954. doi: 10.1007/s00125-023-05878-8. Epub 2023 Feb 10.
6
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
J Clin Invest. 2012 Jun;122(6):2176-94. doi: 10.1172/JCI41636. Epub 2012 May 1.
8
NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet.
J Biol Chem. 2021 Jan-Jun;296:100714. doi: 10.1016/j.jbc.2021.100714. Epub 2021 Apr 27.
9
ChREBP regulates fructose-induced glucose production independently of insulin signaling.
J Clin Invest. 2016 Nov 1;126(11):4372-4386. doi: 10.1172/JCI81993. Epub 2016 Sep 26.

引用本文的文献

1
HCF-1 as a key modulator of OGT function and O-GlcNAcylation in the liver.
Sci Rep. 2025 Aug 3;15(1):28328. doi: 10.1038/s41598-025-11813-1.
4
Thyroid-Stimulating Hormone: An Important Target for the Prevention of Nonalcoholic Fatty Liver Disease.
Physiol Res. 2025 Apr 30;74(2):175-187. doi: 10.33549/physiolres.935453.
5
Comprehensive understanding of context-specific functions of PHF2 in lipid metabolic tissues.
Sci Rep. 2025 Mar 17;15(1):9074. doi: 10.1038/s41598-025-93438-y.
6
Cohesin positions the epigenetic reader Phf2 within the genome.
EMBO J. 2025 Feb;44(3):736-766. doi: 10.1038/s44318-024-00348-2. Epub 2025 Jan 2.
7
Identification of a Polypeptide Inhibitor of -GlcNAc Transferase with Picomolar Affinity.
J Am Chem Soc. 2024 Sep 25;146(38):26320-26330. doi: 10.1021/jacs.4c08656. Epub 2024 Sep 14.
8
Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic.
Front Med (Lausanne). 2023 Nov 27;10:1294267. doi: 10.3389/fmed.2023.1294267. eCollection 2023.
10
The Function of MondoA and ChREBP Nutrient-Sensing Factors in Metabolic Disease.
Int J Mol Sci. 2023 May 16;24(10):8811. doi: 10.3390/ijms24108811.

本文引用的文献

2
Triglyceride Metabolism in the Liver.
Compr Physiol. 2017 Dec 12;8(1):1-8. doi: 10.1002/cphy.c170012.
3
Sweet Sixteenth for ChREBP: Established Roles and Future Goals.
Cell Metab. 2017 Aug 1;26(2):324-341. doi: 10.1016/j.cmet.2017.07.004.
4
Nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) is regulated by O-GlcNAc transferase.
Free Radic Biol Med. 2017 Sep;110:196-205. doi: 10.1016/j.freeradbiomed.2017.06.008. Epub 2017 Jun 15.
5
Protein O-GlcNAcylation: emerging mechanisms and functions.
Nat Rev Mol Cell Biol. 2017 Jul;18(7):452-465. doi: 10.1038/nrm.2017.22. Epub 2017 May 10.
7
ChREBP regulates fructose-induced glucose production independently of insulin signaling.
J Clin Invest. 2016 Nov 1;126(11):4372-4386. doi: 10.1172/JCI81993. Epub 2016 Sep 26.
8
How the glycosyltransferase OGT catalyzes amide bond cleavage.
Nat Chem Biol. 2016 Nov;12(11):899-901. doi: 10.1038/nchembio.2173. Epub 2016 Sep 12.
9
Hormonal and Metabolite Regulation of Hepatic Glucokinase.
Annu Rev Nutr. 2016 Jul 17;36:389-415. doi: 10.1146/annurev-nutr-071715-051145. Epub 2016 May 4.
10
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
Dig Dis Sci. 2016 May;61(5):1282-93. doi: 10.1007/s10620-016-4054-0. Epub 2016 Feb 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验